lobbying_activities: 968525

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
968525 87ce1c44-4c58-48c5-a4fc-2977fc77cfbe Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2010 second_quarter PHA H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Reconciliation Act of 2010 H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   420000 0 0 2010-07-20T09:47:17.813000-04:00